<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1025-0255</journal-id>
<journal-title><![CDATA[Revista Archivo Médico de Camagüey]]></journal-title>
<abbrev-journal-title><![CDATA[Arch méd Camagüey]]></abbrev-journal-title>
<issn>1025-0255</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Ciencias Médicas de Camagüey]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1025-02552023000100081</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Prescripción de clonazepam tabletas en el municipio Santa Clara]]></article-title>
<article-title xml:lang="en"><![CDATA[Clonazepam tablets prescription in Santa Clara municipality]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Alemán-Fernández]]></surname>
<given-names><![CDATA[Eliezer]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Central Farmacia Principal Municipal de Santa Clara ]]></institution>
<addr-line><![CDATA[Villa Clara ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<volume>27</volume>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1025-02552023000100081&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1025-02552023000100081&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1025-02552023000100081&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción: Las benzodiazepinas son medicamentos utilizados para el tratamiento de la ansiedad y los trastornos del sueño, así como relajantes musculares y anticonvulsivantes. A pesar de que no se aconseja su uso para tratamientos prolongados, algunos pacientes lo utilizan de forma continuada lo cual se asocia con la dependencia física y síntomas de abstinencia moderada a severa. El clonazepam es uno de las benzodiazepinas con propiedades ansiolíticas y antiepilépticas.  Objetivo: Determinar el aumento en la prescripción del medicamento clonazepam de 1mg tabletas en el municipio Santa Clara.  Métodos: Se realizó una investigación observacional, retrospectiva, descriptiva y transversal, que se correspondió con un estudio de uso de medicamentos, del tipo prescripción-indicación del medicamento clonazepam de 1mg tabletas, durante el período junio 2021 a junio 2023. El universo lo conformaron 5 819 pacientes que constituían la totalidad de los pacientes de tipo ambulatorio con dicha prescripción al final del estudio.  Resultados: En cuanto al sexo, al final del estudio, la distribución mostró un predominio del sexo femenino. Se evidenció un incremento de un 198 % de los pacientes y predominó el grupo de edades de más de 59 años (55,3 %).  Conclusiones: Existe una alta tendencia en el uso del clonazepam, sobre todo en personas de la tercera edad, las cuales son las más susceptibles a la aparición de efectos indeseables con consecuencias lamentables.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction: Benzodiazepines are drugs used for anxiety and sleep disorders, as well as muscle relaxants and anticonvulsive. Despite being discouraged in prolonged treatments, some patients have chronic use, which is associated with the development of physical dependence, manifested in moderate to severe withdrawal symptoms. Clonazepam is one such benzodiazepine which has antiepileptic as well as anxiolytic properties.  Objective: To determine the increase in prescription of clonazepam 1mg tablets in Santa Clara municipality.  Methods: An observational, retrospective, descriptive and cross-sectional investigation was carried out, which corresponded with a medications use study, of prescription-indication type. It was conducted aimed at assessing the prescription of the medication clonazepam 1mg tablets during the period from June 2021 to June 2023. The universe was built by 5819 patients which constituted the totality of ambulatory patients with such prescription at the end of the study.  Results: Regarding sex, at the end of the study, the distribution showed a predominance of the female sex. It was evidenced an increase of 198 % of patients and a predominance of patients over 59 years of age (55.33 %).  Conclusions:  The results showed a high trend in the use of clonazepam, mainly in elderly patients, which are the most susceptible to the appearance of undesirable effects and unfortunate consequences.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[CLONAZEPAM]]></kwd>
<kwd lng="es"><![CDATA[BENZODIAZEPINAS]]></kwd>
<kwd lng="es"><![CDATA[MEDICAMENTOS BAJO PRESCRIPCIÓN]]></kwd>
<kwd lng="es"><![CDATA[TRASTORNOS RELACIONADOS CON SUSTANCIAS]]></kwd>
<kwd lng="es"><![CDATA[SALUD DEL ANCIANO]]></kwd>
<kwd lng="en"><![CDATA[CLONAZEPAM]]></kwd>
<kwd lng="en"><![CDATA[BENZODIAZEPINES]]></kwd>
<kwd lng="en"><![CDATA[PRESCRIPTION DRUGS]]></kwd>
<kwd lng="en"><![CDATA[SUBSTANCE-RELATED DISORDERS]]></kwd>
<kwd lng="en"><![CDATA[HEALTH OF THE ELDERLY]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marín]]></surname>
<given-names><![CDATA[GH]]></given-names>
</name>
<name>
<surname><![CDATA[del Mauro]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Marín]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Urtasun]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Marín]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Nucher]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Consumo de benzodiacepinas y fármacos Z en una organización de la seguridad social nacional argentina: ¿uso racional o excesivo]]></article-title>
<source><![CDATA[Salud Colect]]></source>
<year>2021</year>
<volume>17</volume>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[Programme on substance abuse: Rational use of benzodiazepines]]></source>
<year>1996</year>
<publisher-loc><![CDATA[Copenhagen ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[He]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Fei]]></surname>
<given-names><![CDATA[X.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk of dementia in long-term benzodiazepine users: evidence from a meta-analysis of observational studies.]]></article-title>
<source><![CDATA[J Clin Neurol]]></source>
<year>2019</year>
<volume>15</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>9-19</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[WHO Collaborating Centre for Drug Statistics Methodology]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zorzanelli]]></surname>
<given-names><![CDATA[RT]]></given-names>
</name>
<name>
<surname><![CDATA[Giordani]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Guaraldo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Matos]]></surname>
<given-names><![CDATA[GC]]></given-names>
</name>
<name>
<surname><![CDATA[Brito Junior]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[Goncalves de Oliveira]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Consumption of the benzodiazepine clonazepam (Rivotril®) in Rio de Janeiro State, Brazil, 2009-2013: an ecological study.]]></article-title>
<source><![CDATA[Ciência &amp; Saúde Coletiva]]></source>
<year>2019</year>
<volume>24</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>3129-40</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kurko]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Saastamoinen]]></surname>
<given-names><![CDATA[LK]]></given-names>
</name>
<name>
<surname><![CDATA[Tuulio-Henriksson]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Taiminen]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Tiihonen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Airaksinen]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trends in the long-term use of benzodiazepine anxiolytics and hypnotics: a national register study for 2006 to 2014.]]></article-title>
<source><![CDATA[Pharmacoepidemiol Drug Saf]]></source>
<year>2018</year>
<volume>27</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>674-82</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<collab>American Geriatrics Society</collab>
<article-title xml:lang=""><![CDATA[American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults]]></article-title>
<source><![CDATA[JAGS]]></source>
<year>2019</year>
<volume>67</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>674-98</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gallagher]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Ryan]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Byrne]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kennedy]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[O&#8217;Mahony]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[STOPP (Screening Tool of Older Person&#8217;s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment): Consensus validation.]]></article-title>
<source><![CDATA[Int J Clin Pharmacol Ther]]></source>
<year>2008</year>
<volume>46</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>72-83</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez Carranza]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Vademecum Académico de Medicamentos.]]></source>
<year>2013</year>
<edition>6ª</edition>
<publisher-loc><![CDATA[México D.F ]]></publisher-loc>
<publisher-name><![CDATA[McGraw-Hill Interamericana]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Domínguez]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Collares]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ormaechea]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Tamosiunas]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uso racional de benzodiazepinas: hacia una mejor prescripción.]]></article-title>
<source><![CDATA[Rev Urug Med Interna]]></source>
<year>2016</year>
<volume>1</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barboza]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Artagaveytia]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Speranza]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Domínguez]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Tamosiunas]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Segundo estudio de consumo de benzodiazepinas en una población uruguaya (2014-2018): el problema avanza.]]></article-title>
<source><![CDATA[Rev Méd Urug]]></source>
<year>2022</year>
<volume>38</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<collab>Fundación FEMEBA</collab>
<article-title xml:lang=""><![CDATA[Benzodiazepinas: Uso crónico y desprescripción.]]></article-title>
<source><![CDATA[Folia Doc]]></source>
<year>2020</year>
<volume>XXIII</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ng]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
<name>
<surname><![CDATA[Le Couter]]></surname>
<given-names><![CDATA[DG]]></given-names>
</name>
<name>
<surname><![CDATA[Hilmer]]></surname>
<given-names><![CDATA[SN.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Deprescribing benzodiazepines in older patients: impact of interventions targeting physicians, pharmacists, and patients.]]></article-title>
<source><![CDATA[Drugs Aging]]></source>
<year>2018</year>
<volume>35</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>493-521</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Urtasun]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Noble]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cañas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bustin]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Regueiro]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Triskier]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uso de benzodiacepinas y fármacos relacionados en el seguro social para adultos mayores de Argentina.]]></article-title>
<source><![CDATA[Medicina]]></source>
<year>2022</year>
<volume>82</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Davies]]></surname>
<given-names><![CDATA[SJC]]></given-names>
</name>
<name>
<surname><![CDATA[Jacob]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Rudoler]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Zaheer]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[de Oliveira]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Kurdyak]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benzodiazepine prescription in Ontario residents aged 65 and over: a population-based study from 1998 to 2013.]]></article-title>
<source><![CDATA[Ther Adv Psychopharmacol]]></source>
<year>2018</year>
<volume>8</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>99-114</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brandt]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Alessi-Severini]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Singer]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Leong]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Novel Measures of Benzodiazepine and Z-Drug Utilisation Trends in a Canadian Provincial Adult Population (2001-2016).]]></article-title>
<source><![CDATA[J Ther Popul Pharamcologie Clin]]></source>
<year>2019</year>
<volume>26</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wingard]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Taipale]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Reutfors]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Westerlund]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bodén]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Tiihonen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Initiation and long-term use of benzodiazepines and Z-drugs in bipolar disorder.]]></article-title>
<source><![CDATA[Bipolar Disord]]></source>
<year>2018</year>
<volume>20</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>634-46</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morin]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Inoue]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Kushida]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Poyares]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Winkelman]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Endorsement of European guideline for the diagnosis and treatment of insomnia by the World Sleep Society.]]></article-title>
<source><![CDATA[Sleep Med]]></source>
<year>2021</year>
<volume>81</volume>
<page-range>124-6</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Crescenzo]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[D&#8217;Alò]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
<name>
<surname><![CDATA[Ostinell]]></surname>
<given-names><![CDATA[EG]]></given-names>
</name>
<name>
<surname><![CDATA[Ciabattini]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Di Franco]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Watanabe]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis.]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2022</year>
<volume>400</volume>
<page-range>170-84</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[O&#8217;Mahony]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[O&#8217;Sullivan]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Byrne]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[O&#8217;Connor]]></surname>
<given-names><![CDATA[MN]]></given-names>
</name>
<name>
<surname><![CDATA[Ryan]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Gallagher]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[STOPP/START criteria for potentially inappropriate prescribing in older people: version 2.]]></article-title>
<source><![CDATA[Age Ageing]]></source>
<year>2015</year>
<volume>44</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>213-8</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Villén Romero]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Troncoso Mariño]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Com I Quan Cal Fer Una Reducció Gradual de la Dosi Dels Medicaments?]]></article-title>
<source><![CDATA[Butlletí Informació Terapèutica]]></source>
<year>2015</year>
<volume>26</volume>
<numero>7</numero>
<issue>7</issue>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
